BACKGROUND: @entity859 is the first-line medication in @entity1 with @entity4710 . Because it is cleared so rapidly from the circulation, recurrence of @entity4710 after initial successful conversion may occur. OBJECTIVE: This study was conducted to evaluate the role of oral @entity1855 administration to control early recurrences of @entity4710 after @entity859 infusion. METHODS: @entity1 with acute @entity4710 and no contraindications for @entity859 or @entity1855 treatment were included in study. All @entity1 received an @entity859 protocol (6 mg rapid bolus intravenous injection followed by two repeated doses of 12 mg if necessary). @entity1 in the @entity859 -only group did not received any other medications but @entity1 in the @entity859 / @entity1855 group received 40 mg @entity1855 orally immediately after converting the rhythm to sinus rhythm. All @entity1 were followed up for 6 h in the acute care area of the emergency department under continuous cardiac monitoring. RESULTS: A total of 113 @entity1 were assessed for eligibility and 92 @entity1 were randomized into two groups ( @entity859 only versus @entity859 / @entity1855 ). There was no statistically significant difference in @entity4710 recurrence rate between the two groups in the first 30 min after treatment. Recurrence rate was statistically significantly lower in the @entity859 / @entity1855 group than in the @entity859 -only group between 30 and 120 min after treatment and thereafter. Two @entity1 in the @entity859 -only group experienced @entity1671 and one @entity1 in the @entity859 / @entity1855 group experienced decreased systolic blood pressure. CONCLUSION: Oral @entity1855 can decrease @entity4710 recurrence after successful control with intravenous @entity859 .

Oral @entity1855 in XXXX recurrence control: a randomized clinical trial.

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients', 'patient'] @entity1671 :: ('MESH:D005483', 'Disease') :: ['flushing'] @entity859 :: ('MESH:D000241', 'Chemical') :: ['Adenosine', 'adenosine'] @entity1855 :: ('MESH:D014700', 'Chemical') :: ['verapamil'] @entity4710 :: ('MESH:D013617', 'Disease') :: ['paroxysmal supraventricular tachycardia']
@entity4710 :: (MESH:D013617,Disease) :: ['paroxysmal supraventricular tachycardia']
